Percutaneous lower extremity arterial interventions using plain balloon angioplasty vs. cryoplasty with the PolarCath®: a randomized trial




Background


Target lesion revascularization (TLR) with primary percutaneous transluminal angioplasty (PTA) vs. cryoplasty (CRYO) in the treatment of de novo infrainguinal disease has not been well defined in randomized trials.




Methods


In this prospective, two-center randomized trial of PTA vs. CRYO of infrainguinal vessels, the primary endpoint of TLR was evaluated at 6 months. Secondary endpoints included the rate of bailout stenting because of suboptimal acute angiographic results (defined as a residual narrowing of ≥30% or type C or higher dissection) and target vessel revascularization (TVR). Major Adverse events including death and amputations were recorded. A two-sample t test was used to compare the two groups on the continuous variables. For categorical variables, cross-tabular analysis was conducted with nonparametric tests ( χ 2 and Fisher’s Exact Test) used to test for significant differences.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Coronary stenting with MGuard: extended follow-up of first human trial
  2. Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté vs. TAXUS Express stents in small vessel coronary stenting
  3. Treatment of STEMI with neither PCI nor thrombolysis
  4. Definite stent thrombosis: a 2-center New Zealand registry

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Percutaneous lower extremity arterial interventions using plain balloon angioplasty vs. cryoplasty with the PolarCath®: a randomized trial

Full access? Get Clinical Tree
Get Clinical Tree app for offline access